Research Grant Programs - Children's Cancer Research Fund support researchers studying childhood cancer to advance safer treatments, address survivors' late effects, and reduce health disparities.
Funder: Children's Cancer Research Fund
Due Dates (Anticipated): November 2026 (Clinical Trials full application) | March 2027 (Accelerating Impact LOI) | April 2027 (Survivorship & Disparities LOI) | June 2027 (Accelerating Impact full application) | August 2027 (Clinical Trials LOI) | August 2027 (Survivorship & Disparities full application)
Funding Amounts: Up to $125,000 annually for 24 months (Impact, Survivorship, Disparities); up to $1,000,000 total for 36 months (Clinical Trials)
Summary: Supports childhood cancer research advancing safer treatments, improving survivorship, and reducing health disparities.
Key Information: Each Principal Investigator may submit only one Letter of Intent to CCRF per calendar year across all mechanisms.
Children’s Cancer Research Fund (CCRF) funds research toward safer, more effective, less toxic treatments for children with cancer. Its four award mechanisms address hard-to-treat cancers, survivorship, and health disparities. Accelerating Impact supports pre-clinical basic and translational research, including pilot studies, feasibility studies, secondary data analysis, and new research methods or technologies. Accelerating Hope supports clinical trials, prioritizing Phase 0–2 studies.
Healthy After Cancer supports interventions that prevent, minimize, or address late effects of therapy for childhood, adolescent, and young adult survivors. Eliminating Disparities supports research on inequities in incidence, presentation, access to care, treatment outcomes, adverse events, and survivorship. It prioritizes identifying modifiable risks, explaining mechanisms, or reducing disparities over simply describing them.